HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation

Cell Death and Disease

Volumn 6, Issue 8, 2015, Pages

  Han, S J ^a,b   Min, H J ^b,c   Yoon, S C ^a   Ko, E A ^c   Park, S J ^c   Yoon, J H ^a,c   Shin, J S ^c   Seo, K Y ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 8; MIP 1 PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCT; UNCLASSIFIED DRUG; AGER PROTEIN, MOUSE; HMGB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC INFLAMMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXTRACELLULAR SPACE; EYE INFLAMMATION; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IRRADIATION; MOUSE; NONHUMAN; OCULAR SURFACE DISEASE; OCULAR SURFACE INFLAMMATION; OXIDATION REDUCTION POTENTIAL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; PTERYGIUM; RADIATION INJURY; TRANSIENT TRANSFECTION; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION; WESTERN BLOTTING; ADVERSE EFFECTS; AGONISTS; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL NUCLEUS; CHEMISTRY; CONJUNCTIVA; CYTOPLASM; GENE EXPRESSION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; RADIATION RESPONSE; SIGNAL TRANSDUCTION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; CELL LINE; CELL NUCLEUS; CONJUNCTIVA; CYTOPLASM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MICE; MICE, INBRED BALB C; PROTEIN TRANSPORT; PTERYGIUM; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 84989283932     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.199     Document Type: Article

References (51)

1. Ueda T, Yoshida M. HMGB proteins and transcriptional regulation. Biochim Biophys Acta 2010; 1799: 114-118.
2. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22: 5551-5560.
3. Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291: C1318-C1325.
4. Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE et al. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol 2009; 182: 5800-5809.
5. Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 2011; 14: 1315-1335.
6. Lamkanfi M, Sarkar A, Vande Walle L, Vitari AC, Amer AO, Wewers MD et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 2010; 185: 4385-4392.
7. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009; 10: 148-155.
8. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
9. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5: 825-830.
10. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367-388.
11. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139-162.
12. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251.
13. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33: 564-573.
14. Schiraldi M, Raucci A, Munoz LM, Livoti E, Celona B, Venereau E et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012; 209: 551-563.
15. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A et al. Masquerader: High mobility group box-1 and cancer. Clin Cancer Res 2007; 13: 2836-2848.
16. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342.
17. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-892.
18. Erlandsson Harris H, Andersson U. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004; 34: 1503-1512.
19. Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H et al. High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46: 2598-2603.
20. Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005; 52: 3639-3645.
21. Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 2004; 50: 1586-1594.
22. Maxia C, Perra MT, Demurtas P, Minerba L, Murtas D, Piras F et al. Expression of survivin protein in pterygium and relationship with oxidative DNA damage. J Cell Mol Med 2008; 12: 2372-2380.
23. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: Role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004; 23: 195-228.
24. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-819.
25. Said T, Dutot M, Martin C, Beaudeux JL, Boucher C, Enee E et al. Cytoprotective effect against UV-induced DNA damage and oxidative stress: Role of new biological UV filter. Eur J Pharm Sci 2007; 30: 203-210.
26. Austin P, Jakobiec FA, Iwamoto T. Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 1983; 90: 96-109.
27. Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trends and perspectives (Review). Int J Mol Med 2009; 23: 439-447.
28. Hoffman RS, Power WJ. Current options in pterygium management. Int Ophthalmol Clin 1999; 39: 15-26.
29. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004; 73: 119-131.
30. Ramachandran S, Prasad NR. Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet- B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem Biol Interact 2008; 176: 99-107.
31. Kang R, Livesey KM, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 as an autophagy sensor in oxidative stress. Autophagy 2011; 7: 904-906.
32. Tang D, Kang R, Livesey KM, Zeh HJ 3rd, Lotze MT. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal 2011; 15: 2185-2195.
33. Yu Y, Tang D, Kang R. Oxidative stress-mediated HMGB1 biology. Front Physiol 2015; 6: 93.
34. Golu T, Mogoanta L, Streba CT, Pirici DN, Malaescu D, Mateescu GO et al. Pterygium: Histological and immunohistochemical aspects. Rom J Morphol Embryol 2011; 52: 153-158.
35. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 2007; 26: 1129-1139.
36. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220: 35-46.
37. Berthelot F, Fattoum L, Casulli S, Gozlan J, Marechal V, Elbim C. The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration. J Innate Immun 2012; 4: 41-58.
38. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003; 48: 2052-2058.
39. Gornik K, Moore P, Figueiredo M, Vandenplas M. Expression of Toll-like receptors 2, 3, 4, 6, 9, and MD-2 in the normal equine cornea, limbus, and conjunctiva. Vet Ophthalmol 2011; 14: 80-85.
40. Li J, Shen J, Beuerman RW. Expression of toll-like receptors in human limbal and conjunctival epithelial cells. Mol Vis 2007; 13: 813-822.
41. Cook EB, Stahl JL, Esnault S, Barney NP, Graziano FM. Toll-like receptor 2 expression on human conjunctival epithelial cells: A pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. Ann Allergy Asthma Immunol 2005; 94: 486-497.
42. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012; 209: 1519-1528.
43. Dement GA, Treff NR, Magnuson NS, Franceschi V, Reeves R. Dynamic mitochondrial localization of nuclear transcription factor HMGA1. Exp Cell Res 2005; 307: 388-401.
44. Stumbo AC, Cortez E, Rodrigues CA, Henriques MG, Porto LC, Barbosa HS et al. Mitochondrial localization of non-histone protein HMGB1 during human endothelial cell- Toxoplasma gondii infection. Cell Biol Int 2008; 32: 235-238.
45. Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, Billiar TR et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 2013; 33: 567-577.
46. Ortega E, Hinchado MD, Martin-Cordero L, Asea A. The effect of stress-inducible extracellular Hsp72 on human neutrophil chemotaxis: A role during acute intense exercise. Stress 2009; 12: 240-249.
47. de la Coba F, Aguilera J, de Galvez MV, Alvarez M, Gallego E, Figueroa FL et al. Prevention of the ultraviolet effects on clinical and histopathological changes, as well as the heat shock protein-70 expression in mouse skin by topical application of algal UV-absorbing compounds. J Dermatol Sci 2009; 55: 161-169.
48. Kim RO, Rhee JS, Won EJ, Lee KW, Kang CM, Lee YM et al. Ultraviolet B retards growth, induces oxidative stress, and modulates DNA repair-related gene and heat shock protein gene expression in the monogonont rotifer, Brachionus sp. Aquat Toxicol 2011; 101: 529-539.
49. Youn JH, Shin JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006; 177: 7889-7897.
50. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 2008; 180: 5067-5074.
51. Liu S, Tobias R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 1997; 30: 455-463.